CN Stock MarketDetailed Quotes

002728 Teyi Pharmaceutical Group

Watchlist
  • 9.55
  • +0.08+0.84%
Not Open Apr 25 15:00 CST
4.88BMarket Cap31.11P/E (TTM)

Teyi Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-45.88%164.61M
20.38%1.07B
27.83%745.29M
39.79%538.38M
56.50%304.16M
16.94%886.57M
10.96%583.05M
7.51%385.14M
-0.02%194.35M
19.83%758.16M
Operating revenue
-45.88%164.61M
20.38%1.07B
27.83%745.29M
39.79%538.38M
56.50%304.16M
16.94%886.57M
10.96%583.05M
7.51%385.14M
-0.02%194.35M
19.83%758.16M
Other operating revenue
----
74.15%741.44K
----
96.55%399.33K
----
84.10%425.74K
----
41.75%203.17K
----
-51.81%231.26K
Total operating cost
-13.39%156.73M
10.23%768.83M
10.40%530.07M
14.41%362.94M
29.16%180.96M
15.65%697.48M
13.59%480.12M
11.50%317.22M
-10.75%140.11M
6.34%603.08M
Operating cost
-18.88%91.71M
3.58%467.99M
2.74%315.31M
8.61%222.05M
22.03%113.06M
26.89%451.83M
23.87%306.91M
25.87%204.45M
6.65%92.65M
8.86%356.08M
Operating tax surcharges
-52.42%1.56M
24.46%12.28M
26.44%7.78M
35.39%5.63M
43.37%3.28M
6.40%9.87M
0.41%6.15M
6.71%4.16M
2.13%2.29M
13.27%9.27M
Operating expense
1.51%36.07M
48.52%174.36M
57.60%121.72M
73.50%80.62M
114.98%35.53M
-1.13%117.4M
-1.63%77.23M
-17.39%46.47M
-48.74%16.53M
20.03%118.74M
Administration expense
7.56%17.6M
12.43%66.31M
13.01%47.18M
10.91%30.68M
20.62%16.36M
3.09%58.99M
-0.78%41.74M
-0.44%27.66M
-3.49%13.57M
4.13%57.22M
Financial expense
-151.80%-1.32M
-77.44%4.82M
-72.13%5.62M
-75.25%4.08M
-60.49%2.54M
-10.90%21.39M
-6.79%20.16M
2.09%16.5M
-50.32%6.43M
-42.11%24M
-Interest expense (Financial expense)
-65.48%1.39M
-43.83%16.36M
-43.14%14.03M
-48.34%9.55M
-43.17%4.02M
-1.29%29.13M
-1.94%24.68M
-2.06%18.49M
-47.11%7.07M
-30.91%29.51M
-Interest Income (Financial expense)
-86.09%-2.81M
-45.87%-11.98M
-75.63%-8.74M
-139.55%-5.7M
-111.40%-1.51M
-40.84%-8.21M
-28.71%-4.97M
20.67%-2.38M
-12.27%-715.52K
-233.38%-5.83M
Research and development
9.02%11.1M
13.30%43.06M
16.29%32.47M
10.48%19.88M
17.71%10.18M
0.62%38.01M
5.12%27.92M
0.08%17.99M
0.19%8.65M
3.50%37.78M
Credit Impairment Loss
-45.22%1.53M
97.62%-35.01K
869.74%1.46M
338.68%1.71M
925.10%2.8M
18.94%-1.47M
83.34%-189.8K
-699.46%-718.26K
31.25%-339.31K
-320.94%-1.81M
Asset Impairment Loss
----
---13.16M
----
----
----
----
----
----
----
12.07%-23.1M
Other net revenue
-10.79%3.43M
-168.51%-5.11M
-41.39%4.63M
-31.88%3.71M
1,186.71%3.85M
151.41%7.46M
-9.60%7.9M
-41.66%5.44M
-95.21%298.95K
-96.94%-14.51M
Invest income
--21.47K
6.29%360.81K
-20.44%270.08K
----
----
-94.62%339.46K
-94.62%339.46K
-95.84%262.39K
----
-58.53%6.31M
Asset deal income
----
199.24%122.08K
195.67%120.63K
392.29%120.36K
----
-57.20%40.8K
--40.8K
--24.45K
----
132.57%95.33K
Other revenue
79.22%1.88M
-11.02%7.6M
-63.96%2.78M
-68.11%1.87M
64.04%1.05M
113.62%8.55M
115.89%7.71M
102.40%5.87M
15.56%638.25K
26.23%4M
Operating profit
-91.10%11.31M
49.21%293.27M
98.37%219.85M
144.22%179.15M
132.95%127.04M
39.82%196.55M
-0.63%110.83M
-11.69%73.36M
24.98%54.54M
141.44%140.57M
Add:Non operating Income
-98.07%120.29
44.07%106.8K
-89.63%7.33K
-90.01%7.04K
-68.82%6.24K
-99.03%74.13K
-99.04%70.74K
-98.95%70.45K
-99.71%20K
3,461.63%7.61M
Less:Non operating expense
363.02%119.13K
29.20%384.25K
-11.01%158.52K
-55.92%78.52K
-85.14%25.73K
-72.35%297.4K
-75.36%178.14K
-35.00%178.14K
15.39%173.09K
-79.15%1.08M
Total profit
-91.19%11.19M
49.24%292.99M
98.42%219.7M
144.48%179.08M
133.57%127.02M
33.46%196.32M
-6.33%110.72M
-18.19%73.25M
8.07%54.38M
176.10%147.1M
Less:Income tax cost
-90.54%2.04M
119.74%39.82M
140.91%31.22M
128.67%26.96M
147.22%21.55M
-10.21%18.12M
-15.54%12.96M
-17.10%11.79M
0.75%8.72M
113.30%20.18M
Net profit
-91.32%9.15M
42.07%253.18M
92.79%188.48M
147.51%152.13M
130.96%105.47M
40.41%178.2M
-4.96%97.77M
-18.39%61.46M
9.59%45.67M
189.66%126.92M
Net profit from continuing operation
-91.32%9.15M
42.07%253.18M
92.79%188.48M
147.51%152.13M
130.96%105.47M
40.41%178.2M
-4.96%97.77M
-18.39%61.46M
9.59%45.67M
189.66%126.92M
Net profit of parent company owners
-91.32%9.15M
42.07%253.18M
92.79%188.48M
147.51%152.13M
130.96%105.47M
40.41%178.2M
-4.96%97.77M
-18.39%61.46M
9.59%45.67M
189.66%126.92M
Earning per share
Basic earning per share
-90.91%0.03
35.09%0.77
84.38%0.59
135.00%0.47
57.14%0.33
-8.06%0.57
-37.25%0.32
-45.95%0.2
5.00%0.21
181.82%0.62
Diluted earning per share
-90.63%0.03
35.09%0.77
78.13%0.57
130.00%0.46
60.00%0.32
-8.06%0.57
-37.25%0.32
-45.95%0.2
0.00%0.2
181.82%0.62
Other composite income
Total composite income
-91.32%9.15M
42.07%253.18M
92.79%188.48M
147.51%152.13M
130.96%105.47M
40.41%178.2M
-4.96%97.77M
-18.39%61.46M
9.59%45.67M
189.66%126.92M
Total composite income of parent company owners
-91.32%9.15M
42.07%253.18M
92.79%188.48M
147.51%152.13M
130.96%105.47M
40.41%178.2M
-4.96%97.77M
-18.39%61.46M
9.59%45.67M
189.66%126.92M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -45.88%164.61M20.38%1.07B27.83%745.29M39.79%538.38M56.50%304.16M16.94%886.57M10.96%583.05M7.51%385.14M-0.02%194.35M19.83%758.16M
Operating revenue -45.88%164.61M20.38%1.07B27.83%745.29M39.79%538.38M56.50%304.16M16.94%886.57M10.96%583.05M7.51%385.14M-0.02%194.35M19.83%758.16M
Other operating revenue ----74.15%741.44K----96.55%399.33K----84.10%425.74K----41.75%203.17K-----51.81%231.26K
Total operating cost -13.39%156.73M10.23%768.83M10.40%530.07M14.41%362.94M29.16%180.96M15.65%697.48M13.59%480.12M11.50%317.22M-10.75%140.11M6.34%603.08M
Operating cost -18.88%91.71M3.58%467.99M2.74%315.31M8.61%222.05M22.03%113.06M26.89%451.83M23.87%306.91M25.87%204.45M6.65%92.65M8.86%356.08M
Operating tax surcharges -52.42%1.56M24.46%12.28M26.44%7.78M35.39%5.63M43.37%3.28M6.40%9.87M0.41%6.15M6.71%4.16M2.13%2.29M13.27%9.27M
Operating expense 1.51%36.07M48.52%174.36M57.60%121.72M73.50%80.62M114.98%35.53M-1.13%117.4M-1.63%77.23M-17.39%46.47M-48.74%16.53M20.03%118.74M
Administration expense 7.56%17.6M12.43%66.31M13.01%47.18M10.91%30.68M20.62%16.36M3.09%58.99M-0.78%41.74M-0.44%27.66M-3.49%13.57M4.13%57.22M
Financial expense -151.80%-1.32M-77.44%4.82M-72.13%5.62M-75.25%4.08M-60.49%2.54M-10.90%21.39M-6.79%20.16M2.09%16.5M-50.32%6.43M-42.11%24M
-Interest expense (Financial expense) -65.48%1.39M-43.83%16.36M-43.14%14.03M-48.34%9.55M-43.17%4.02M-1.29%29.13M-1.94%24.68M-2.06%18.49M-47.11%7.07M-30.91%29.51M
-Interest Income (Financial expense) -86.09%-2.81M-45.87%-11.98M-75.63%-8.74M-139.55%-5.7M-111.40%-1.51M-40.84%-8.21M-28.71%-4.97M20.67%-2.38M-12.27%-715.52K-233.38%-5.83M
Research and development 9.02%11.1M13.30%43.06M16.29%32.47M10.48%19.88M17.71%10.18M0.62%38.01M5.12%27.92M0.08%17.99M0.19%8.65M3.50%37.78M
Credit Impairment Loss -45.22%1.53M97.62%-35.01K869.74%1.46M338.68%1.71M925.10%2.8M18.94%-1.47M83.34%-189.8K-699.46%-718.26K31.25%-339.31K-320.94%-1.81M
Asset Impairment Loss -------13.16M----------------------------12.07%-23.1M
Other net revenue -10.79%3.43M-168.51%-5.11M-41.39%4.63M-31.88%3.71M1,186.71%3.85M151.41%7.46M-9.60%7.9M-41.66%5.44M-95.21%298.95K-96.94%-14.51M
Invest income --21.47K6.29%360.81K-20.44%270.08K---------94.62%339.46K-94.62%339.46K-95.84%262.39K-----58.53%6.31M
Asset deal income ----199.24%122.08K195.67%120.63K392.29%120.36K-----57.20%40.8K--40.8K--24.45K----132.57%95.33K
Other revenue 79.22%1.88M-11.02%7.6M-63.96%2.78M-68.11%1.87M64.04%1.05M113.62%8.55M115.89%7.71M102.40%5.87M15.56%638.25K26.23%4M
Operating profit -91.10%11.31M49.21%293.27M98.37%219.85M144.22%179.15M132.95%127.04M39.82%196.55M-0.63%110.83M-11.69%73.36M24.98%54.54M141.44%140.57M
Add:Non operating Income -98.07%120.2944.07%106.8K-89.63%7.33K-90.01%7.04K-68.82%6.24K-99.03%74.13K-99.04%70.74K-98.95%70.45K-99.71%20K3,461.63%7.61M
Less:Non operating expense 363.02%119.13K29.20%384.25K-11.01%158.52K-55.92%78.52K-85.14%25.73K-72.35%297.4K-75.36%178.14K-35.00%178.14K15.39%173.09K-79.15%1.08M
Total profit -91.19%11.19M49.24%292.99M98.42%219.7M144.48%179.08M133.57%127.02M33.46%196.32M-6.33%110.72M-18.19%73.25M8.07%54.38M176.10%147.1M
Less:Income tax cost -90.54%2.04M119.74%39.82M140.91%31.22M128.67%26.96M147.22%21.55M-10.21%18.12M-15.54%12.96M-17.10%11.79M0.75%8.72M113.30%20.18M
Net profit -91.32%9.15M42.07%253.18M92.79%188.48M147.51%152.13M130.96%105.47M40.41%178.2M-4.96%97.77M-18.39%61.46M9.59%45.67M189.66%126.92M
Net profit from continuing operation -91.32%9.15M42.07%253.18M92.79%188.48M147.51%152.13M130.96%105.47M40.41%178.2M-4.96%97.77M-18.39%61.46M9.59%45.67M189.66%126.92M
Net profit of parent company owners -91.32%9.15M42.07%253.18M92.79%188.48M147.51%152.13M130.96%105.47M40.41%178.2M-4.96%97.77M-18.39%61.46M9.59%45.67M189.66%126.92M
Earning per share
Basic earning per share -90.91%0.0335.09%0.7784.38%0.59135.00%0.4757.14%0.33-8.06%0.57-37.25%0.32-45.95%0.25.00%0.21181.82%0.62
Diluted earning per share -90.63%0.0335.09%0.7778.13%0.57130.00%0.4660.00%0.32-8.06%0.57-37.25%0.32-45.95%0.20.00%0.2181.82%0.62
Other composite income
Total composite income -91.32%9.15M42.07%253.18M92.79%188.48M147.51%152.13M130.96%105.47M40.41%178.2M-4.96%97.77M-18.39%61.46M9.59%45.67M189.66%126.92M
Total composite income of parent company owners -91.32%9.15M42.07%253.18M92.79%188.48M147.51%152.13M130.96%105.47M40.41%178.2M-4.96%97.77M-18.39%61.46M9.59%45.67M189.66%126.92M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Daishin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg